Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00542776 · ClinicalTrials.gov registry record
Impact of Immunosuppression in IBD Patients on Response to Influenza Vaccine
A clinical trial of Inflammatory Bowel Disease (IBD) and Influenza Vaccine, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 146
- Enrollment target
- 1
- Study location
NCT00542776: Completed study of Inflammatory Bowel Disease (IBD) and Influenza Vaccine, sponsored by Boston Children's Hospital.
NCT00542776 is a study of Inflammatory Bowel Disease (IBD) and Influenza Vaccine that has completed, run by Boston Children's Hospital. The registered enrollment target is 146 participants, below the 262-participant average among 12 other Inflammatory Bowel Disease (IBD) trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00542776, a study of Inflammatory Bowel Disease (IBD) and Influenza Vaccine, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 146 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the efficacy and safety of influenza vaccine in patients with inflammatory bowel disease (IBD) on immunosuppressive therapy with IBD patients on aminosalicylates and healthy historical controls.
Conditions Studied
Interventions
- OTHER blood draw
Study Locations (1)
Massachusetts
- Children's Hospital Boston - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2007-10 |
| Est. Completion | 2008-02 |
What the finished NCT00542776 record still lists
NCT00542776 is an observational study that tracks outcomes without assigning an intervention. The registered 146 participants enrollment target is mid-sized for trials with a published cap, below the 262-participant average among 12 other Inflammatory Bowel Disease (IBD) trials with a reported enrollment target (44% lower).
The record links to 5 conditions, with Inflammatory Bowel Disease (IBD) appearing as the primary indexed condition, and to 1 intervention - of which blood draw is the first listed.
NCT00542776 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00542776 about?
NCT00542776 is a clinical study titled "Impact of Immunosuppression in IBD Patients on Response to Influenza Vaccine". The purpose of this study is to compare the efficacy and safety of influenza vaccine in patients with inflammatory bowel disease (IBD) on immunosuppressive therapy with IBD patients on aminosalicylates and healthy historical controls.
What is the current status of trial NCT00542776?
This trial is currently completed. The enrollment target is 146 participants. The study started on 2007-10. Estimated completion is 2008-02.
What conditions does trial NCT00542776 study?
This clinical trial studies the following conditions: Inflammatory Bowel Disease (IBD), Influenza Vaccine, Immunosuppressed or Non-Immunosuppressed, Antibody Titers, Seroprotective Titers.
What interventions are being tested in trial NCT00542776?
The interventions under investigation include: blood draw (OTHER).
Who is sponsoring clinical trial NCT00542776?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00542776 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammatory Bowel Disease (IBD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00542776's enrollment target sits among peer trials
146 5th of 12 higher than 8 of 12 other Inflammatory Bowel Disease (IBD) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Inflammatory Bowel Disease (IBD) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
RECRUITING
-
Study of DISC-0974-201 in Participants With IBD and Anemia
RECRUITING · Phase 2
-
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
RECRUITING
-
Evaluation of the SMART IBD App in Pediatric IBD
RECRUITING · NA
-
IBD Pregnancy Registry
RECRUITING
-
Family Members At INcreased-risk for Developing Inflammatory Bowel Disease
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03490929 · 146 participants · Phase 4
CEUS for Blunt Abdominal Trauma in Children
- NCT04755062 · 146 participants · NA
A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans
- NCT04867954 · 146 participants
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
- NCT05051618 · 146 participants · NA
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia